HDS signs LOI with PharmaLife to market Clotamin in Russia

Download PDF Copy

Apr 10 2012

Sunpeaks Ventures, Inc. (OTC Bulletin Board: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has signed a Letter of Intent with PharmaLife^® for placement of Clotamin^® with leading pharmacies in the Russian Federation.

The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

"Potential demand for Clotamin is worldwide and this Letter of Intent to export into the Russian marketplace is the first agreement intended to meet that international demand," stated Mackie A. Barch, CEO of Sunpeaks. "We look forward to working closely with PharmaLife and our new possible distributors to build market awareness and sales of Clotamin across Russia. If successful, the Company intends to utilize this expansion strategy to penetrate other international markets that share similar potential."

Source:

Sunpeaks Ventures, Inc.

Posted in: Pharmaceutical News

Comments (0)

Download PDF Copy

Suggested Reading

Healthcare workforce perspectives on patient experience improvement in private hospitals

New national dataset maps how far Australians must drive to reach essential healthcare services

New platform enables unbiased evaluation of AI algorithms for diabetic eye screening

Aging populations are redefining the value of a healthy life year

Mpox clade Ib transmitted in a healthcare setting outside Africa

Study reveals significant financial strain on families seeking mental healthcare

Artificial empathy in healthcare platforms and future directions

Aston University and PFE Medical partner to create biodegradable gloves from food waste

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.